AGP Picks
View all

Health Press Barbados
Provided by AGP

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 1, 2026

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia
an hour ago

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
an hour ago

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Indeterminate GlobeNewswire
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
an hour ago

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Indeterminate GlobeNewswire
Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases
an hour ago

Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases

Indeterminate GlobeNewswire
ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026
2 hours ago

ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026

Indeterminate GlobeNewswire
Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib
2 hours ago

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

Indeterminate GlobeNewswire
Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development
5 hours ago

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development

Indeterminate GlobeNewswire
Curium Announces a Strategic Investment of Over €32 million in Saclay, France
5 hours ago

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

Indeterminate GlobeNewswire
Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026
5 hours ago

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

Indeterminate GlobeNewswire
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
5 hours ago

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
6 hours ago

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension

Indeterminate GlobeNewswire
SEIMC Launches Precision Gallbladder-Preserving Treatment to Safeguard Biliary Health
7 hours ago

SEIMC Launches Precision Gallbladder-Preserving Treatment to Safeguard Biliary Health

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Health Press Barbados

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.